Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3355 |
|
| Actual shortage: | 217 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-OXAZEPAM | 30MG | TABLET | Resolved | 2018-05-08 | 2018-07-03 | 48846 |
| APO-OXAZEPAM | 30MG | TABLET | Resolved | 2018-12-12 | 2019-01-28 | 69455 |
| APO OXTRIPHYLLINE TAB 100MG | 100MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 18939 |
| APO OXTRIPHYLLINE TAB 200MG | 200MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 18942 |
| APO OXTRIPHYLLINE TAB 300MG | 300MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 18954 |
| APO PEN VK | 200000UNIT | POWDER FOR SOLUTION | Resolved | 2017-03-11 | 2019-03-09 | 429 |
| APO PEN VK | 480000UNIT | POWDER FOR SOLUTION | Resolved | 2017-03-11 | 2019-03-08 | 432 |
| APO PIROXICAM CAP 10MG | 10MG | CAPSULE | Resolved | 2018-03-05 | 2018-10-30 | 41862 |
| APO PIROXICAM CAP 10MG | 10MG | CAPSULE | Resolved | 2021-01-18 | 2021-04-15 | 131883 |
| APO PIROXICAM CAP 20MG | 20MG | CAPSULE | Resolved | 2023-03-16 | 2023-03-23 | 187232 |
| APO PREDNISONE TAB 50MG | 50MG | TABLET | Resolved | 2017-06-13 | 2017-07-31 | 12692 |
| APO PREDNISONE TAB 50MG | 50MG | TABLET | Resolved | 2024-01-05 | 2024-01-12 | 215230 |
| APO PREDNISONE TAB 50MG | 50MG | TABLET | Resolved | 2023-03-30 | 2023-06-09 | 188418 |
| APO PREDNISONE TAB 50MG | 50MG | TABLET | Resolved | 2018-05-15 | 2018-08-31 | 49506 |
| APO PREDNISONE TAB 5MG | 5MG | TABLET | Resolved | 2020-05-08 | 2020-06-02 | 114315 |
| APO PREDNISONE TAB 5MG | 5MG | TABLET | Resolved | 2017-04-19 | 2017-05-01 | 7234 |
| APO PREDNISONE TAB 5MG | 5MG | TABLET | Resolved | 2017-10-23 | 2017-11-20 | 26629 |
| APO PREDNISONE TAB 5MG | 5MG | TABLET | Resolved | 2017-06-27 | 2017-07-28 | 14003 |
| APO PREDNISONE TAB 5MG | 5MG | TABLET | Resolved | 2024-03-15 | 2024-03-22 | 222467 |
| APO PREDNISONE TAB 5MG | 5MG | TABLET | Resolved | 2022-01-21 | 2022-01-22 | 153285 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |